Table 2.
Novel medical devices (n=309) | No (%) |
---|---|
Therapeutic area: | |
Cardiovascular | 245 (79) |
Neurologic | 28 (9) |
Orthopedic | 36 (12) |
CE marking year: | |
2005 | 29 (9) |
2006 | 37 (12) |
2007 | 36 (12) |
2008 | 57 (18) |
2009 | 79 (26) |
2010 | 71 (23) |
Firm type: | |
Small (<$1bn) | 134 (44) |
Large (≥$1bn) | 174 (56) |
Food and Drug Administration approval: | |
Yes | 206 (67) |
No | 103 (33) |
Major innovation: | |
Yes | 75 (24) |
No | 234 (76) |